Artificial Intelligence (AI) has recently been shown as an excellent tool for the study of the
liver; however, many obstacles still have to be overcome for the digitalization of real-world …

Cancer is the leading cause of death after liver transplantation (LT). This multicenter case–
control nested study aimed to evaluate the effect of maintenance immunosuppression on …

De novo malignancies constitute an emerging cause of morbidity after solid organ transplant
(SOT), significantly affecting the long-term survival of transplant recipients. Pharmacologic …

Background. Human Schlafen 5 (SLFN5) is reported to inhibit or promote the proliferation of
several specific types of cancer cells by our lab and other researchers. We are curious about …

De novo malignancies (DNMs) following liver transplantation (LT) have been reported as 1
of the major causes of late mortality, being the most common cause of death in the second …

Simple Summary Long-term immunosuppressive therapy following liver transplantation is
associated with an increased risk for the development of de novo lung carcinoma. However …

Kidney transplant (KT) recipients are known to be at risk of developing several cancer types;
however, cancer mortality in this population is underinvestigated. Our study aimed to assess …

Immunosuppression non-adherence is a major cause of graft failure after liver
transplantation. The aim of this study was to evaluate practice surrounding conversion from …

Introduction The study of immune response to SARSCoV-2 infection in different solid organ
transplant settings represents an opportunity for clarifying the interplay between SARS-CoV …

Vascular sarcomas are soft tissue sarcomas characterized by neoplastic cells with a line of
differentiation closely resembling the endothelium of blood vessels. According to the latest …